Persistent Hepatitis C Viremia Following Sofosbuvir/Velpatasvir During Bendamustine‐Rituximab Therapy for Follicular Lymphoma
Clinical Case Reports · 2026-10 · 14 (10)
DOI: 10.1002/ccr3.73585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 23.09.2026. Verfasst von Chisom J Orakwue und 1 weiteren Autor:innen. Beteiligte Einrichtung: Tulane University School of Medicine New Orleans Louisiana USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This is a case of a 67‐year‐old female with follicular lymphoma who developed hepatitis C viremia during chemotherapy and failed treatment with a 12‐week course of sofosbuvir/velpatasvir. This highlights the possibility that chemotherapy may have contributed to failure to achieve sustained virologic response despite otherwise appropriate direct‐acting antiviral therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tulane University School of Medicine New Orleans Louisiana USA.
ORCID-Profile: Chisom J Orakwue, Rade N Pejic
Zitieren
APA
Orakwue, C. J., & Pejic, R. N. (2026). Persistent Hepatitis C Viremia Following Sofosbuvir/Velpatasvir During Bendamustine‐Rituximab Therapy for Follicular Lymphoma. Clinical Case Reports, 14(10). https://doi.org/10.1002/ccr3.73585
Vancouver
Orakwue CJ, Pejic RN. Persistent Hepatitis C Viremia Following Sofosbuvir/Velpatasvir During Bendamustine‐Rituximab Therapy for Follicular Lymphoma. Clinical Case Reports. 2026;14(10). doi:10.1002/ccr3.73585
BibTeX
@article{Orakwue2026,
author = {Orakwue, Chisom J and Pejic, Rade N},
title = {Persistent Hepatitis C Viremia Following Sofosbuvir/Velpatasvir During Bendamustine‐Rituximab Therapy for Follicular Lymphoma},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {10},
doi = {10.1002/ccr3.73585}
}
EUVIMED